Nuage Therapeutics

Nuage

This company develops drug screening assays and medicines targeting intrinsically disordered proteins for patients with cancer and other difficult to treat diseases.

Disruptive Pharma

This company develops a drug formulation platform to improve the solubility and bioavailability of pharmaceutical compounds for the healthcare industry.

D2G Oncology

This company develops genomic drug screening platforms and mouse models to identify genotype-specific cancer treatments for healthcare institutions and pharmaceutical researchers.

STipe Therapeutics

The company develops drugs targeting protein-protein interactions within the STING pathway to treat cancer and autoimmune diseases for healthcare institutions and pharmaceutical firms.

C4 Therapeutics

This biopharmaceutical company develops small-molecule medicines that degrade disease-causing proteins to treat cancer and other difficult diseases for patients and healthcare providers.

Ambagon Therapeutics

The company develops small-molecule stabilisers to modulate protein interactions for the treatment of cancer and other serious diseases.

Momentous Therapeutics

This company develops pan-cancer drugs and therapeutic treatments for the pharmaceutical industry to address challenging biological targets.

Accipiter Biosciences

Accipiter Biosciences develops custom-engineered protein therapies using computational design to treat complex diseases like cancer and autoimmune disorders for the healthcare sector.